Search Within

Yanming Zhang

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Research Letter (2)
Groups
  1. Department of Pathology and Laboratory Medicine (35)
  2. Survivorship Research (35)
  3. Center for Hematologic Malignancies (34)
  4. Department of Medicine (34)
  5. Hematologic Malignancies, Division of (32)
  6. Hematologic Malignancies Research (25)

More Groups

People
  1. Alexander Lesokhin (21)
  2. Heather Landau (19)
  3. Kylee Maclachlan (19)
  4. Malin Hultcrantz (18)
  5. Neha Korde (18)
  6. Ahmet Dogan (16)

More People

Years
  1. 2024 (5)
  2. 2023 (11)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Blood (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Blood Advances (3)
  4. American Journal of Hematology (2)
  5. Blood Cancer Journal (2)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Elsevier Inc. (5)
  3. Nature Publishing Group (3)
  4. John Wiley & Sons, Inc. (2)
  5. American Association for Cancer Research (1)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Para-medullary (PMD) and extra-medullary (EMD) myeloma demonstrate increased copy number aberration, mutational burden, structural variants and genomic complexity compared to marrow-based myeloma
    Meeting Abstract

    Maclachlan, K.; GarceĢs, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors
    Journal Article

    Offin, M.; Aguirre, N.; Yang, S. R.; Sauter, J. L.; Karagkounis, G.; Mohamed, M.; Cercek, A.; Kundra, R.; Zhang, Y.; Wang, H. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save